首页|AECOPD合并呼吸衰竭开展无创呼吸机联合高流量氧疗的效果

AECOPD合并呼吸衰竭开展无创呼吸机联合高流量氧疗的效果

扫码查看
目的 探讨慢阻肺急性加重期(acute exacerbation of chronic obstructive pulmonary disease,AECOPD)合并呼吸衰竭患者开展无创呼吸机联合高流量氧疗(high-flow nasal cannula,HFNC)的临床效果.方法 选取 2022 年 6 月—2023年 6 月兖矿新里程总医院呼吸内科收治的AECOPD合并呼吸衰竭患者 92 例,根据治疗方法的不同分为对照组(n=46)与观察组(n=46).对照组采用无创呼吸机治疗,观察组采用无创呼吸机联合HFNC治疗.对 2 组患者的并发症发生率、再插管率、治疗前后血气指标、肺功能及血清生化指标进行比较.结果 观察组患者并发症总发生率为 6.52%,明显低于对照组的 21.74%(P<0.05).观察组再插管率为 2.17%,与对照组再插管率(8.70%)相比,差异无统计学意义(P>0.05).治疗前组间患者血气指标、肺功能及血清生化指标比较,差异无统计学意义(P>0.05);治疗后观察组血气指标、肺功能及血清生化指标改善均优于对照组(P<0.05).结论 无创呼吸机联合HFNC对于AECOPD合并呼吸衰竭患者病情有良好地控制效果,能够改善其肺功能和呼吸功能,因此在临床中有较高的推广价值.
Effect of Non-Invasive Ventilator Combined With High-Flow Oxygen Therapy in AECOPD Complicated With Respiratory Failure
Objective To discuss the clinical effect of non-invasive ventilator combined with high-flow oxygen therapy(HFNC)in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD)and respiratory failure.Methods A total of 92 patients with AECOPD and respiratory failure admitted to the department of respiratory medicine,Yankuang New Journey General Hospital from June 2022 to June 2023 were divided into control group(n=46)and observation group(n=46)according to different treatment methods.The control group received non-invasive ventilation treatment,while the observation group received non-invasive ventilation combined with HFNC treatment.The incidence of complications,reintubation rate,blood gas indicators before and after treatment,lung function,and serum biochemical indicators between two groups of patients were compared.Results The total incidence of complications in the observation group was 6.52%,which significantly lower than the 21.74%in the control group(P<0.05).The reintubation rate in the observation group was 2.17%,higher than the control group's 8.70%,and the difference was not statistically significant(P>0.05).The differences in blood gas indexes,lung function and serum biochemical indexes between patients before treatment were small(P>0.05),and the improvement of blood gas indexes,lung function and serum biochemical indexes in the observation group after treatment was better than that of the control group(P<0.05).Conclusion Non-invasive ventilator combined with HFNC has a good control effect on the condition of patients with AECOPD and respiratory failure,and can improve their lung and respiratory function,so it has high clinical promotion value.

COPDacute exacerbation phaserespiratory failurenon-invasive ventilatorshigh-flow oxygen inhalationlung function

张扬、韩梅丽、吴静

展开 >

兖矿新里程总医院呼吸内科,山东 济宁 273500

慢性阻塞性肺疾病 急性加重期 呼吸衰竭 无创呼吸机 高流量吸氧 肺功能

2024

中国卫生标准管理
《中国卫生标准管理》杂志社

中国卫生标准管理

影响因子:1.374
ISSN:1674-9316
年,卷(期):2024.15(13)